You are viewing an expired study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Rochester, New York

  • Neoplasms

Purpose:

The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop a measurement to test people who may have been accidentally exposed to radiation.


Criteria:

Inclusion Criteria: - Male or female, age 21 to 70 years old. - Patient undergoing with anti-neoplastic agent(s) known to have genotoxic activity (e.g., cyclophosphamide, 5-FU, cisplatin, Ara-C. - X-irradiation may be considered, so long as a substantial fraction of red marrow is exposed (e.g., femur or chest/trunk region); - treatment could be ongoing therapy or initial therapy.


NCT ID:

NCT00178308


Primary Contact:

Principal Investigator
Yuhchyau Chen, MD, Ph.D
Universtiy of Rochester, Dept of Radiation Oncology


Backup Contact:

N/A


Location Contact:

Rochester, New York
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.